Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
6.96
-0.17 (-2.38%)
Dec 5, 2025, 4:00 PM EST - Market closed
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $328.75 million as of December 5, 2025. Its market cap has decreased by -0.10% in one year.
Market Cap
328.75M
Enterprise Value
226.74M
1-Year Change
-0.10%
Ranking
Category
Stock Price
$6.96
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $328.75M, a decrease of -38.94%. That is a compound annual growth rate of -8.98%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 328.75M | 1.20% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 925.43B |
| Johnson & Johnson | 494.70B |
| AbbVie | 406.92B |
| UnitedHealth Group | 307.72B |
| AstraZeneca | 283.29B |
| Novartis AG | 257.47B |
| Merck & Co. | 253.84B |
| Thermo Fisher Scientific | 218.08B |